loadpatents
name:-0.15926504135132
name:-0.019152164459229
name:-0.01238489151001
Wittrup; Karl Dane Patent Filings

Wittrup; Karl Dane

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wittrup; Karl Dane.The latest application filed is for "synergistic tumor treatment with il-2 and integrin-binding-fc fusion protein".

Company Profile
13.19.34
  • Wittrup; Karl Dane - Chestnut Hill MA
  • Wittrup; Karl Dane - Lebanon NH
  • Wittrup; Karl Dane - Boston MA
  • WITTRUP; Karl Dane - Cambridge MA
  • Wittrup; Karl Dane - Menlo Park CA
  • Wittrup; Karl Dane - Urbana IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods to specifically profile protease activity at lymph nodes
Grant 11,448,643 - Bhatia , et al. September 20, 2
2022-09-20
Polyclonal mixtures of antibodies, and methods of making and using them
Grant 11,390,964 - Walker , et al. July 19, 2
2022-07-19
Synergistic Tumor Treatment With Il-2 And Integrin-binding-fc Fusion Protein
App 20220193197 - WITTRUP; Karl Dane ;   et al.
2022-06-23
Combination Immunotherapy Dosing Regimen For Immune Checkpoint Blockade
App 20220096601 - Wang; Chensu ;   et al.
2022-03-31
Combination immunotherapy dosing regimen for immune checkpoint blockade
Grant 11,235,032 - Wang , et al. February 1, 2
2022-02-01
Methods For Identifying Chimeric Antigen Receptor-targeting Ligands And Uses Thereof
App 20210340524 - IRVINE; Darrell J. ;   et al.
2021-11-04
Chimeric Antigen Receptor-targeting Ligands And Uses Thereof
App 20210338833 - IRVINE; Darrell J. ;   et al.
2021-11-04
Multi-specific Antibodies With Affinity For Human A33 Antigen And Dota Metal Complex And Uses Thereof
App 20210301014 - CHEAL; Sarah ;   et al.
2021-09-30
Synergistic tumor treatment with an extended pharmacokinetic IL-2 and integrin-binding-Fc fusion protein
Grant 11,096,989 - Wittrup , et al. August 24, 2
2021-08-24
Multiple Specificity Binders Of Cxc Chemokines And Uses Thereof
App 20210246199 - ANGELINI; Alessandro ;   et al.
2021-08-12
Bispecific Antibody Compositions And Related Methods For Improved Pretargeted Radioimmunotherapies
App 20210171651 - Green; Damian J. ;   et al.
2021-06-10
Monoclonal Antibodies That Bind Human Cd161 And Uses Thereof
App 20210122826 - WITTRUP; Karl Dane ;   et al.
2021-04-29
Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof
Grant 10,988,534 - Cheal , et al. April 27, 2
2021-04-27
Combination Tumor Treatment With An Integrin-binding-fc Fusion Protein And Immune Stimulator
App 20210077576 - COCHRAN; Jennifer R. ;   et al.
2021-03-18
Methods of treating cancer cells expressing tumor-associated integrins
Grant 10,888,603 - Wittrup , et al. January 12, 2
2021-01-12
Immunomodulatory Fusion Protein-metal Hydroxide Complexes And Methods Thereof
App 20200405850 - IRVINE; Darrell J. ;   et al.
2020-12-31
Synthetic Oncolytic Lnp-replicon Rna And Uses For Cancer Immunotherapy
App 20200281994 - Irvine; Darrell J. ;   et al.
2020-09-10
Polyclonal Mixtures Of Antibodies, And Methods Of Making And Using Them
App 20200278354 - Walker; Laura M. ;   et al.
2020-09-03
Combination Immunotherapy Dosing Regimen For Immune Checkpoint Blockade
App 20200230208 - WANG; Chensu ;   et al.
2020-07-23
Polyclonal mixtures of antibodies, and methods of making and using them
Grant 10,684,289 - Walker , et al.
2020-06-16
Multi-specific Antibodies With Affinity For Human A33 Antigen And Dota Metal Complex And Uses Thereof
App 20200140543 - CHEAL; Sarah ;   et al.
2020-05-07
Collagen-localized Immunomodulatory Molecules And Methods Thereof
App 20200102370 - WITTRUP; Karl Dane ;   et al.
2020-04-02
Combination tumor treatment with an integrin-binding-Fc fusion protein and immune stimulator
Grant 10,603,358 - Cochran , et al.
2020-03-31
Synergistic Tumor Treatment With Il-2 And Integrin-binding-fc Fusion Protein
App 20190343925 - WITTRUP; Karl Dane ;   et al.
2019-11-14
Method of treating cancer with a multiple integrin binding Fc fusion protein
Grant 10,350,266 - Cochran , et al. July 16, 2
2019-07-16
Methods To Specifically Profile Protease Activity At Lymph Nodes
App 20190128873 - Bhatia; Sangeeta N. ;   et al.
2019-05-02
Synergistic Tumor Treatment With Il-2, An Integrin-binding-fc Fusion Protein, And A Cancer Vaccine
App 20190054145 - WITTRUP; Karl Dane ;   et al.
2019-02-21
Synergistic tumor treatment with antibodies targeting PD-1, PD-L1 or CTLA4 and integrin-binding-Fc-fusion protein
Grant 10,166,273 - Wittrup , et al. J
2019-01-01
Combination Tumor Treatment With An Integrin-binding-fc Fusion Protein And Immune Modulator
App 20180369329 - COCHRAN; Jennifer R. ;   et al.
2018-12-27
Synergistic tumor treatment with extended-PK IL-2 and therapeutic agents
Grant 9,844,582 - Wittrup , et al. December 19, 2
2017-12-19
Protein-chaperoned T-cell Vaccines
App 20170252417 - Irvine; Darrell ;   et al.
2017-09-07
Synergistic Tumor Treatment With Il-2, A Therapeutic Antibody, And A Cancer Vaccine
App 20170224777 - WITTRUP; Karl Dane ;   et al.
2017-08-10
Synergistic Tumor Treatment With Il-2, A Therapeutic Antibody, And An Immune Checkpoint Blocker
App 20170216403 - WITTRUP; Karl Dane ;   et al.
2017-08-03
Synergistic Tumor Treatment With Il-2 And Integrin-binding-fc-fusion Protein
App 20170216402 - WITTRUP; Karl Dane ;   et al.
2017-08-03
Polyclonal Mixtures Of Antibodies, And Methods Of Making And Using Them
App 20160313345 - Walker; Laura M. ;   et al.
2016-10-27
Antibody-based constructs directed against tyrosine kinase receptors
Grant 9,464,136 - Wittrup , et al. October 11, 2
2016-10-11
Reversible Masking Of Pore-forming Proteins For Macromolecular Delivery
App 20150174265 - Wittrup; Karl Dane ;   et al.
2015-06-25
Synergistic Tumor Treatment With Extended-pk Il-2 And Therapeutic Agents
App 20150132254 - Wittrup; Karl Dane ;   et al.
2015-05-14
Synergistic Tumor Treatment With Extended-pk Il-2 And Adoptive Cell Therapy
App 20150017120 - WITTRUP; Karl Dane ;   et al.
2015-01-15
Compositions And Methods For Macromolecular Drug Delivery
App 20140080766 - Pirie; Christopher Michael ;   et al.
2014-03-20
Engineered proteins with high affinity for DOTA chelates
Grant 8,648,176 - Davis Orcutt , et al. February 11, 2
2014-02-11
Antibody-based Constructs Directed Against Tyrosine Kinase Receptors
App 20130216543 - Wittrup; Karl Dane ;   et al.
2013-08-22
Cell display libraries
Grant 8,450,247 - Peelle , et al. May 28, 2
2013-05-28
Mutant interleukin-2 (IL-2) polypeptides
Grant 8,349,311 - Wittrup , et al. January 8, 2
2013-01-08
Engineered Proteins Including Mutant Fibronectin Domains
App 20120270797 - Wittrup; Karl Dane ;   et al.
2012-10-25
Mutant Interleukin-2 (il-2) Polypeptides
App 20110306752 - WITTRUP; KARL DANE ;   et al.
2011-12-15
Cell display libraries
App 20060003387 - Peelle; Beau R. ;   et al.
2006-01-05
Methods for increasing secretion of overexpressed proteins
Grant 5,773,245 - Wittrup , et al. June 30, 1
1998-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed